
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
ImClone Systems is a fully integrated global biopharmaceutical company committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. On November 24, 2008, ImClone Systems became a wholly-owned subsidiary of Eli Lilly and Company (NYSE: LLY)
Monoclonal antibodies and biopharmaceutical company
Imclone systems, a wholly-owned subsidiary of eli lilly and company operates in the Biotechnology research industry.
Imclone systems, a wholly-owned subsidiary of eli lilly and company's revenue is 11m - 100m
Imclone systems, a wholly-owned subsidiary of eli lilly and company has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.